Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression

Toxicologic Pathology

Volumn 40, Issue 2, 2012, Pages 186-204

  Peterson, Richard A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

flow cytometry; FOXP3; IPEX; lymphocytes; regulatory T cells; Scurfy mouse; immunopathology

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; GRANZYME; HEAT SHOCK PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; MICRORNA; PERFORIN; STEROID; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CHRONIC STRESS; DENDRITIC CELL; EFFECTOR CELL; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; IPEX SYNDROME; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; HOMEOSTASIS; HUMANS; MICE; PHENOTYPE; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; VERTEBRATA;

EID: 84858768465     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311430693     Document Type: Article

References (188)

1. Aandahl E. M. Michaelsson J. Moretto W. J. Hecht F. M. Nixon D. F. (2004). Human CD4+CD25+ regulatory T cells control T-cell responses to Human Immunodeficiency Virus and Cytomegalovirus antigens. J Virol 78, 2454–9.
2. Abraham C. Cho J. (2009). Interleukin-23/TH 17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15(7), 1090–100.
3. Abraham C. Medzhitov R. (2011). Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterol 140, 1729–37.
4. Akdis M. (2009). Immune tolerance in allergy. Curr Opin Immunol 21, 700–7.
5. Aluvihare V. R. Kallikourdis M. Betz A. G. (2004). Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5, 266–71.
6. Andersson J. Boasso A. Nilsson J. Zhang R. Shire N. J. Lindback S. Shearer G. M. Chougnet C. A. (2005). Cutting edge: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174(6), 3143–7.
7. Annacker O. Asseman C. Read S. Powrie F. (2003). Interleukin-10 in the regulation of T cell-induced colitis. J Autoimmun 20, 277–9.
8. Askenasy N. Kaminitz A. Yarkoni S. (2008). Mechanisms of T regulatory cell function. Autoimmunity Rev 7, 370–5.
9. Atanackovic D. Brunner-Weinzieri M. C. Kroger H. Serke S. Deter H. C. (2002). Acute physiological stress simultaneously alters hormone levels, recruitment of lymphocyte subsets, and production of reactive oxygen species. Immunol Invest 31(2), 73–91.
10. Atanackovic D. Schnee B. Schuch G. Faltz C. Schulze J. Weber C. S. Schafhausen P. Bartels K. Bokermeyer C. Brunner-Weinzieri M. C. Deter H. C. (2006). Acute physiological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells. J Neuroimmunol 176, 141–52.
11. Battaglia M. Stabilini A. Migliavacca B. Horejs-Hoeck J. Kaupper T. Roncarolo M. G. (2006). Rapamycin promotes expansion of functional CD4+CD25+FOXP+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177(12), 8338–47.
12. Beissert S. Schwartz A. Schwartz T. (2006). Regulatory T cells. J Invest Dermatol 126, 15–24.
13. Belkaid Y. Piccirillo A. C. Mendez S. Shevack E. Sacks D. L. (2002). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–7.
14. Belkaid Y. Rouse B. T. (2005). Natural regulatory T cells in infectious disease. Nature Immunol 6(4), 353–60.
15. Bettelli E. Carrier Y. Gao W. Korn T. Strom T. B. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells. Nature 441, 235–8.
16. Bienvenu B. Martin B. Auffray C. Cordier C. Becourt C. Lucas B. (2005). Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 175, 246–53.
17. Biros D. (2008). Anterior chamber-associated immune deviation. Vet Clin Small Anim 38, 309–21.
18. Blaha P. Bigenzahn S. Koporc Z. Scmid M. Langer F. Selzer E. (2003). The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101(7), 2886–93.
19. Bloom D. (2006). CD4+CD25+FOXP3+ regulatory T cells in nonhuman primates. Transplant Rev 20, 121–5.
20. Bluestone J. A. Tang Q. (2005). How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 17, 638–42.
21. Blumberg R. S. (2009). Inflammation in the intestinal tract: Pathogenesis and treatment. Dig Dis 27, 455–64.
22. Brossay L. Tangri S. Bix M. Cardell S. Locksley R. M. Kronenberg M. (1998). Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol 160, 3681–8.
23. Brunkow M. E. Jeffery E. W. Hjerrild K. A. Paeper B. Clark L. B. Yasayko S.-A. Wilkinson J. E. Galas D. Ziegler S. F. Ramsdell F. (2001). Disruption of a new forkhead/winged helix protein, scurfin, results in the fatal lymphoproliferative disorder of the Scurfy mouse. Nat Genetics 27, 68–73.
24. Cabrera R. Tu Z. Xu Y. Firpi R. J. Rosen H. R. Liu C. Nelson D. R. (2004). An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in Hepatitis C Virus infection. Hepatology 40, 1062–71.
25. Caramahlo I. Lopes-Carvahlo T. Ostler D. Zelenay S. Haury M. Demengeot J. (2003). Regulatory T cells selectively express Toll-Like Receptors and are activated by lipolysaccharide. J Exp Med 197, 403–11.
26. Chang C. C. Ciubotariu R. Manavalan J. S. (2002). Tolerization of dendritic cells by T(s) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nature Immunol 3, 237–43.
27. Chen W. Ford M. S. Young K. J. (2003). Role of double-negative regulatory T cells in long-term cardiax xenograft survival. J Immunol 170, 1846–53.
28. Chen W. Perruche S. Li J. (2007). CD4+CD25+ T regulatory cells and TGF-β in mucosal immune system: The good and the bad. Curr Medicinal Chem 14, 2245–9.
29. Chen W. Zhou D. Torrealba J. R. (2005). Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J Immunol 175, 3409–16.
30. Claman H. N. Chaperon E. A. Triplett R. F. (1966). Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med 122, 1167–71.
31. Clark L. B. Appleby M. W. Brunkow M. E. Wilkinson J. E. Ziegler S. F. Ramsdell F. (1999). Cellular and molecular characterization of the Scurfy mouse mutant. J Immunol 162, 2546–54.
32. Cohen J. L. Trenado A. Vasey D. Klatzmann D. Salomon B. L. (2002). CD4+CD25+ immunoregulatory T cells: New therapeutics for graft-versus-host disease. J Exp Med 196, 401–6.
33. Cortesini R. LeMaoult J. Ciubotariu R. Suciu Foca Cortesini N. (2001). CD8+CD28− T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of TH reactivity. Immunol Rev 182, 201–6.
34. Coutinho A. Caramalho I. Seixas E. Demengeot J. (2005). Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Curr Top Microbiol Immunol 293, 43–71.
35. Crome S. Q. Wang A. Y. Levings M. K. (2009). Translational mini-review series on T H 17 cells: Function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 159, 109–19.
36. Cupedo T. Nagasawa M. Weijer K. Blom B. Spits H. (2005). Development and activation of regulatory T cells in the human fetus. Eur J Immunol 35, 383–90.
37. Datta S. Sarvetnick N. (2009). Lymphocyte proliferation in immune-mediated diseases. Trends Immunol 30(9), 430–8.
38. Deaglio S. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204, 1257–65.
39. O.J., De Boer, C.M., van der Loos, P., Teeling, A.C., van der Wal, M.M.M., Teunissen, Immunohistocehmical analysis of regulatory T cell markers FOXP3 and GITR on CD4, +, CD25, +, T cells in normal skin and inflammatory dermatoses, J Histochem and Cytochem, (2007), 55, 9, 891-898
40. De Serres S. A. Yeung M. Y. Mfarrej B. G. Najafian N. (2011). Effect of biologic agents on regulatory T cells. Transplantation Rev 25(3), 110–6.
41. Diamond M. S. Shrestha B. Marri A. Mahan D. Engle M. (2003). B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile Encephalitis Virus. J Virol 77(4), 2578–86.
42. Di Giacinto C. Marinaro M. Sanchez M. Strober W. Boirivant M. (2005). Probiotics ameliorate recurrent TH 1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 174, 3237–46.
43. Dittel B. N. (2008). CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain, Behavior, and Immunity 22, 421–30.
44. Fainboim L. Arruvito L. (2011). Mechanisms involved in the expansion of TREG during pregnancy: role of IL-2/STAT5 signalling. Journal of Repro Immunol 88, 93–8.
45. Fontenot J. D. Gavin M. A. Rudensky A. Y. (2003). FOXP3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 4, 330–6.
46. Fontenot J. D. Rudensky A. Y. (2005). A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor FOXP3. Nature Immunol 6(4), 331–7.
47. Freir E. Weber C. S. Nowottne U. Horn C. Bartels K. Meyer S. Hildebrandt Y. Luetkens T. Cao Y. Pabst C. Muzzulini J. Schnee B. Brunner-Weinzieri M. C. Marangalo M. Bokemeyer C. Deter H.-C. Atanackovic D. (2010). Decrease of CD4+FOXP3+ T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinol 35, 663–73.
48. Fujio K. Okamura T. Yamamoto K. (2010). The family of IL-10-secreting CD4+ T cells. Advances in Immunology 105, 99–129.
49. Garin M. I. (2007). Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells. Blood 109, 2058–65.
50. Germain R. N. (2008). Special regulatory T cell review: A rose by any other name: from suppressor T cells to TREG, approbation to unbridled enthusiasm. Immunol 123, 20–7.
51. Godfrey V. L. Wilkinson J. E. Russell L. B. (1991). X-linked lymphoreticular disease in the Scurfy (sf) mutant mouse. Am J Pathol 138(6), 1379–87.
52. Gregori S. Casorati M. Amuchastegui S. Smiroldo S. Davalli A. M. Adorini L. (2001). Regulatory T cells induced by 1-Alpha-25-Dihydroxyvitamin D3 and Mycophenolate Mofetil treatment mediate transplantation tolerance. J Immunol 167(4), 1945–53.
53. Greshon R. K. Kondo K. (1971). Infectious immunological tolerance. Immunology 21, 903–14.
54. Grossman W. J. (2004). Differential expression of Granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104, 2840–8.
55. Guerin L. R. Prins J. R. Robertson S. A. (2009). Regulatory T-cells and immune tolerance in pregnancy: A new target for infertility treatment? Human Repro Update 15(5), 517–35.
56. Han C. H. Li H. F. Wang Y. X. Zhang M. Wang Y. Yin M. (2005). The influence of Mycophenolate Mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients. Zhonghua YiXue ZaZhi 85(19), 1327–32.
57. Heikkinen J. Mottonen M. Alanen A. Lassila O. (2004). Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 136, 373–8.
58. Hesse M. Piccirillo C. A. Belkaid Y. Prufer J. Mentink-Kane M. Leusink M. Cheever A. W. Wynn T. A. (2004). The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172, 3157–66.
59. Hezova R. Slaby O. Faltejskova P. Mikulkova Z. Buresova I. Muthu Raja K. R. Hodek J. Ovesna J. Michalek J. (2010). MicroRNA-342, microRNA-191, and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cellular Immunol 260, 70–4.
60. Hori S. Carvahlo T. L. Demengeot J. (2002). CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32, 1282–91.
61. Hori S. Nomura T. Sakaguchi S. (2003). Control of regulatory T cell development by the transcription factor FOXP3. Science 299, 1057–61.
62. Huang W. H. Yan Y. Li J. De Boer B. House A. K. Bishop G. A. (2003). A short course of Mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of Interleukin-4 and alloantibody responses. Transplantation 76(8), 1159–65.
63. Ikehara Y. Yasunami Y. Kodama S. (2000). CD4+ Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 105, 1761–7.
64. Jager A. Kuchroo V. K. (2010). Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72, 173–84.
65. Jiang S. Game D. S. Davies D. (2005). Activated CD1d-restricted natural killer T cells secrete IL-2: Innate help for CD4+CD25+ regulatory T cells? Eur J Immunol 35, 1193–200.
66. Jiang H. Zhang S. I. Pernis B. (1992). Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256, 1213–5.
67. Joetham A. (2007). Naturally occurring lung CD4+CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J Immunol 178, 1433–42.
68. A., Joshi, T.W., Vahlenkamp, H., Garg, W.W.F., Tompkins, M.B., Tompkins, Preferential replication of FIV in activated CD4, +, CD25, +, T cells independent of cellular proliferation, Virol, (2004), 321, 307-322
69. Kapp J. A. Bucy R. P. (2008). CD8+ suppressor T cells resurrected. Human Immunol 69, 715–20.
70. Kapp J. A. Kapp L. M. McKenna K. C. (2004). γδ T cells play an essential role in several forms of tolerance. Immunol Res 29(1), 93–102.
71. Kapp J. A. Ke Y. (1997). The role of γδ TCR-bearing T cells in oral tolerance. In Proceedings of the 72nd Forum in Immunology: Tolerance and Immunity in the Mucosal Immune System, pp. 561–7.
72. Ke Y. Kapp J. A. (1996). Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156, 916–21.
73. Ke Y. Pearce K. Lake J. P. Ziegler H. K. Kapp J. A. (1997). γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 158, 3610–8.
74. Khan S. Burt D. J. Ralph C. Thistlethwaite F. C. Hawkins R. E. Elkord E. (2011). Tremelimumab (anti-CTLA-4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells. Clinical Immunol 138, 85–96.
75. Korn T. Bettelli E. Gao W. Awasthi A. Jager A. (2007). IL-21 initiates an alternative pathway to induce proinflammatory TH 17 cells. Nature 448, 484–7.
76. Korn T. Bettelli E. Oukka M. Kuchroo V. K. (2009). IL-17 and TH 17 cells. Annu Rev Immunol 27, 485–517.
77. Krejsgaard T. Gjerdrum L. M. Ralfkiaer E. Lauenborg B. Eriksen K. W. Mathiesen A.-M. Bovin L. F. Gniadecki R. Geisler C. Ryder L. P. Zhang Q. Wasik M. A. Odum N. Woetmann A. (2008). Malignant TREG express low molecular splice forms of FOXP3 in Sézary syndrome. Leukemia 22, 2230–9.
78. Kronenberg M. (1994). Antigens recognized by γδ T cells. Curr Opin Immunol 6, 64–71.
79. Kullberg M. C. Jankovic D. Gorelick P. L. Caspar P. Letterio J. J. Cheever A. W. Sher A. (2002). Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196, 505–15.
80. Kuniyasu Y. Takahashi T. Itoh M. Shimizu J. Toda G. Sakaguchi S. (2000). Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell population. Int Immunol 12, 1145–55.
81. M., Kursar, K., Bonhagen, J., Fensterle, A., Kohler, R., Hurwitz, T., Kamradt, S.S.E., Kaufman, H.-W., Mittrucker, Regulatory CD4, +, CD25, +, T cells restrict memory CD8, +, T cell responses, J Exp Med, (2002), 196, 1585-1592
82. Larsen C. P. Elwood E. T. Alexander D. Z. Ritchie S. C. Hendrix R. Tucker-Burden C. (1996). Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381(6581), 434–8.
83. Le N. T. Chao N. (2007). Regulating regulatory T cells. Bone Marrow Transplant 39, 1–9.
84. Lehner T. (2008). Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation. Immunol 123, 40–4.
85. LeMaoult J. Krawice-Radanne I. Dausset J. Carosella E. D. (2004). HLA-GI-expressing antigen presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 101, 7064–9.
86. Lenert P. Brummel R. Field E. H. Ashman R. F. (2005). TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 25(1), 29.
87. Li B. Greene M. I. (2008). Special regulatory T cell review: FOXP3 biochemistry in regulatory T cells—how diverse signals regulate suppression. Immunol 123, 17–9.
88. Li X. Braun J. Wei B. (2011). Regulatory B cells in autoimmune diseases and mucosal immune homeostasis. Autoimmunity 44(1), 58–68.
89. Lim H. W. Broxmeyer H. E. Kim C. H. (2006). Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 177, 840–51.
90. Liston A. Nutsch K. M. Farr A. G. Lund J. M. Rasmussen J. P. Koni P. A. Rudensky A. Y. (2008). Differentiation of regulatory FOXP3+ T cells in the thymic cortex. Proc Nat Acad Sciences 105(33), 11903–8.
91. Liu F. Liu J. Chen Y. Song L. He Q. Chen J. (2010). CD4+CD25+FOXP3+ regulatory T cell depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS ONE 5(11), 1–11.
92. Lourenco E. V. La Cava A. (2011). Natural regulatory T cells in autoimmunity. Autoimmunity 44(1), 33–42.
93. Lundgren A. Suri-Payer E. Enarsson K. Svennerholm A. M. Lundin B. S. (2003). Helicobacter pylori-specific CD4+CD25 high regulatory cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71, 1755–62.
94. C.S., Ma, G.G.J., Chew, N., Simpson, Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3, J Exp Med, (2008), 205, 1551
95. Maggi E. Cosmi L. Liotta F. Romagnani P. Romagnani S. Annunziato F. (2005). Thymic regulatory T cells. Autoimmunity Rev 4, 579–86.
96. Malek T. R. Yu A. Zhu L. Matsutani T. Adeegbe D. Bayer A. L. (2008). IL-2 family of cytokines in T regulatory cell development and homeostasis. J Clin Immunol 28, 635–9.
97. Mangan P. R. Harrington L. E. O’Quinn D. B. Helms W. S. Bullard D. C. (2006). Transforming growth factor-β induces development of the TH 17 lineage. Nature 441, 231–4.
98. Menetrier-Caux C. Gobert M. Caux C. (2009). Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 69, 7895–8.
99. Mitchell G. F. Miller J. F. (1968). Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med 128, 821–37.
100. Mizoguchi E. Mizoguchi A. Preffer F. I. Bhan A. K. (2000). Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 12(5), 597–605.
101. Montagnoli C. Bacci A. Bozza S. Gaziano R. Mosci P. Sharpe A. H. Romani L. (2002). B7/CD28-dependent CD4+CD25+ regulatory T-cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169, 6298–308.
102. Mosier D. E. (1967). A requirement for two cell types for antibody formation in vitro. Science 158, 1573–5.
103. Mowat A. M. (1994). Oral tolerance and regulation of immunity to dietary antigens. In Handbook of Mucosal Immunology (Ogra P. L. Mestecky J. Lamm M. E. Strober W. McGhee J. R. Bienenstock J., eds.), pp. 185–201. Academic Press, San Diego, CA.
104. Muller Y. D. Golshayan D. Ehirchiou D. Wekerle T. Seebach J. D. Buhler L. H. (2009). T regulatory cells in xenotransplantation. Xenotransplantation 16, 121–8.
105. M.E., Munk, B., Schoel, S., Modrow, R.W., Karr, R.A., Young, S.S.E., Kaufmann, T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-Kilodalton heat shock protein, J Immunol, (1989), 143, 2844-2849
106. Nakamura T. Sonoda K. H. Faunce D. E. Gumperz J. Yamamura T. Miyake S. Stein-Streilein J. (2003). CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 171, 1266–71.
107. S., Nandakumar, C.C.T., Miller, U., Kumarguru, T regulatory cells: An overview and intervention techniques to modulate allergy outcome, Clin Mol Allergy, (2009), 7, 5-11
108. Nasr I. W. Wang Y. Gao G. Deng S. Diggs L. Rothstein D. M. Tellides G. Lakkis F. G. Dai Z. (2005). Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol 174, 6161–8.
109. Niederkorn J. Y. (2008). Emerging concepts in CD8+ T regulatory cells. Curr Opin Immunol 20, 327–31.
110. Nistala K. Wedderburn L. R. (2009). TH 17 and regulatory T cells: Rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatol 48, 602–6.
111. Nizar S. Meyer B. Galustian C. Kumar D. Dalgleish A. (2010). T regulatory cells, the evolution of targeted immunotherapy. Biochim Biophys Acta 1806, 7–17.
112. Ochs H. D. Khattri R. Bennett C. L. Brunkow M. E. (2002). Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and the Scurfy mutant mouse. Immunol Allergy Clin of North America 22, 357–68.
113. O’Connor R. A. Anderton S. M. (2008). FOXP3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 193, 1–11.
114. Ohkura N. Hamaguchi M. Sakaguchi S. (2011). FOXP3+ regulatory T cells: Control of FOXP3 expression by pharmacological agents. Trends Pharmacol Sci 32(3), 158–66.
115. Okumura K. Takemori T. Tokuhisa T. Tada T. (1977). Specific enrichment of the suppressor T cell bearing I-J determinants: Parallel functional and serological characterizations. J Exp Med 146, 1234–45.
116. Orihara K. Nakae S. Pawankar R. Saito H. (2008). Role of regulatory and proinflammatory T cell populations in allergic diseases. WAO J 1, 9–14.
117. Oswald-Richter K. Grill S. M. Shariat N. Leelawong M. Sundrud M. S. Haas D. W. Unutmaz D. (2004). HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLOS Biology 2(7), 955–66.
118. Ozdemir C. Akdis M. Akdis C. A. (2009). T regulatory cells and their counterparts: Masters of immune regulation. Clin Exp Allergy 39, 626–39.
119. Pandiyan P. Zheng L. Ishihara S. Reed J. Lenardo M. J. (2007). CD4+CD25+FOXP3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nature Immunol 8, 1353–62.
120. Patel D. D. (2001). Escape from tolerance in the human X-linked autoimmunity-allergic dysregulation syndrome and the Scurfy mouse. J Clin Invest 107(2), 155–7.
121. Powrie F. Leach M. W. Mauze S. Menon S. Caddle L. B. Coffman R. L. (1994). Inhibition of TH1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RB high CD4+ T cells. Immunity 1(7), 553–62.
122. Quezada S. A. Jarvinen L. Z. Lind E. F. Noelle R. J. (2004). CD40/CD154 interactions at the interface of tolerance and immunity. Ann Rev Immunol 22(1), 307–28.
123. Read S. Malstrom V. Powrie F. (2000). Cytotoxic T lymphocyte-associated antigen-4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192, 295–302.
124. Reigert A. Bar-Or A. (2008). B-cell-derived Interleukin-10 in autoimmune disease: Regulating the regulators. Nat Rev Immunol 8(6), 486.
125. Riley J. L. June C. H. Blazar B. R. (2009). Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 30, 656–65.
126. Robertson S. A. Guerin L. R. Bromfield J. J. Branson K. M. Ahistrom A. C. Care A. S. (2009). Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 80(5), 1036–45.
127. Robertson S. A. Sharkey D. J. (2001). The role of semen in induction of maternal immune tolerance to pregnancy. Semin Immunol 13, 243–54.
128. Romagnani S. Maggi E. Liotta F. Cosmi L. Annunziato F. (2009). Properties and origin of human TH 17 cells. Mol Immunol 47, 3–7.
129. G., Roncador, P.J., Brown, L., Maestre, S., Hue, J.L., Martinez-Torrecuadrada, K.-L., Ling, S., Pratap, C., Toms, B.C., Fox, V., Cerundolo, F., Powrie, A.H., Banham, Analysis of FOXP3 protein expression in human CD4, +, CD25, +, regulatory T cells at the single-cell level, Eur J Immunol, (2005), 35, 1681-1691
130. Roncarolo M.-G. Battaglia M. (2007). Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nature Rev: Immunol 7, 585–98.
131. Roncarolo M.-G. Gregori S. Battaglia M. Bacchetta R. Fleischhauer K. Levings M. K. (2006). Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212, 28–50.
132. Sakaguchi S. (2005). Naturally arising FOXP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol 6(4), 345–52.
133. Sakaguchi S. Sakaguchi N. Asano M. Itoh M. Toda M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 recpetor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151–64.
134. Sakaguchi S. Yamaguchi T. Nomura T. Ono M. (2008). Regulatory T cells and immune tolerance. Cell 133, 775–87.
135. E.T., Samy, L.A., Parker, C.P., Sharp, K.K.K., Tung, Continuous control of autoimmune disease by antigen-dependent polyclonal CD4, +, CD25, +, regulatory T cells in the regional lymph node, J Exp Med, (2005), 202, 771-781
136. Sarris M. Andersen K. G. Randow F. Mayr L. Betz A. G. (2008). Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402–13.
137. Sasaki Y. Sakai M. Miyazaki S. Higuma S. Shiozaki A. Saito S. (2004). Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10, 347–53.
138. Scholzen A. Minigo G. Plebanski M. (2009). Heroes or villains? T regulatory cells in malaria infection. Trends in Parasitol 26 (1), 16–25.
139. Schwartz R. H. (2005). Natural regulatory T cells and self-tolerance. Nature Immunol 6(4), 327–30.
140. Seo N. Tokura Y. (1999). Downregulation of innate and acquired antitumor immunity by bystander γδ and αβ T lymphocytes with TH2 or Tr1 cytokine profiles. J Interferon and Cytokine Res 19, 555–61.
141. Seo N. Tokura Y. Takigawa M. Egawa K. (1999). Depletion of IL-10 and TGF-β producing regulatory γδ T cells by administering a Daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 163, 242–9.
142. Shalev I. Wong K. M. Foerster K. Zhu Y. Chan C. Maknojia A. Zhang J. Levy G. (2009). The novel CD4+CD25+ regulatory T-cell effector molecule fibrinogem-like protein-2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 49(2), 387–97.
143. Shao L. Jacobs A. R. Johnson V. V. Mayer L. (2005). Activation of CD8+ regulatory T-cells by human placental trophoblasts. J Immunol 174, 7539–47.
144. Shevach E. M. (2009). Mechanisms of FOXP3+ T regulatory cell-mediated suppression. Immunity 30, 636–45.
145. Shoji T. Muniappan A. Guenther D. A. Wain J. C. Houser S. L. Hoerbelt R. (2005). Long-term acceptance of porcine pulmonary allografts without chronic rejection. Transplant Proc 37(1), 72–4.
146. Siegmund K. Feuerer M. Siewert C. (2005). Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097–104.
147. Simpson E. (2008). Special regulatory T-cell review: Regulation of immune responses-examining the role of T cells. Immunol 123, 13–6.
148. Sindram-Trujillo A. P. Scherjon S. A. van Hulst-van Miert P. P. Kanhai H. H. Roelen D. L. Claas F. H. (2004). Comparison of decidual leukocytes following spontaneous vaginal delivery and elective caesarean section in uncomplicated human term pregnancy. J Reprod Immunol 62, 125–37.
149. Strober S. Cheng L. Zeng D. (1996). Double-negative (CD4−CD8− alpha beta+) T cells which promote tolerance induction and regulate autoimmunity. Immunol Rev 149, 217–30.
150. Suvas S. Azkur A. K. Kim B. S. Kumaraguru U. Rouse B. T. (2004). CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172, 4123–32.
151. Taglauer S. Trikhacheva A. S. Slusser J. G. Petroff M. G. (2008). Expression and function of PDCDI at the human maternal-fetal interface. Biol Reprod 79, 562–9.
152. Takenoshita S. Fukushima T. Kumamoto K. Iwadate M. (2002). The role of TGF-β in digestive organ disease. J Gastroenterol 37(12), 991.
153. Tang Q. Krummel M. F. (2006). Imaging the function of regulatory T-cells in vivo. Curr Opin Immunol 18, 496–502.
154. Tao R. de Zoeten E. F. Ozkaynak E. Wang L. Li B. Greene M. I. Wells A. D. Hancock W. W. (2007). Histone deacetylase inhibitors and transplantation. Curr Opin Immunol 19, 589–95.
155. Taylor P. A. Lees C. J. Blazar B. R. (2002). The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493–9.
156. Te Velde A. A. Verstege M. I. Hommes D. W. (2006). Critical appraisal of the current practice in murine TNBS-induced colitis. Inflammatory Bowel Diseases 12(10), 995–9.
157. Thorburn A. N. Hansbro P. M. (2010). Harnessing regulatory T cells to suppress asthma: From potential to therapy. Am J Respir Cell Mol Biol 43, 511–9.
158. Thuere C. Zenclussen M. L. Shumacher A. Langwisch S. Schulte-Wrede U. Teles A. Paeschke S. Volk H. D. Zenclussen A. C. (2007). Kinetics of regulatory T cells during murine pregnancy. Am J Reprod Immunol 58, 514–23.
159. Tian J. Zekzer D. Hanssen L. Lu Y. Olcott A. Kaufman D. L. (2001). Lipopolysaccharide-activated B cells down-regulate TH1 immunity and prevent autoimmune diabetes in non-obese diabetic mice. J Immunol 167(2), 1081–9.
160. Tilburgs T. Roelen D. L. van der Mast B. J. de Groot-Swings G. M. Kleijburg C. Scherjon S. A. Claas F. H. (2008). Evidence for a selective migration of fetus-specific CD4+CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 180, 5737–45.
161. Trentham D. E. Townes A. S. Kang A. H. (1977). Autoimmunity to type II collagen in an experimental model of arthritis. J Exp Med 146(3), 857–68.
162. Trowsdale J. Betz A. G. (2006). Mother’s little helpers: Mechanisms of maternal-fetal tolerance. Nat Immunol 7, 241–6.
163. Trzonkowski P. Bieniaszewska M. Juscinska J. Dobyszuk A. Krzystyniak A. Marek N. Mysliwska J. Hellmann A. (2009). First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CG127− T regulatory cells. Clinical Immunol 133, 22–6.
164. M.A., Vadas, J.F., Miller, I.F., McKenzie, S.E., Chism, F.W., Shen, E.A., Boyse, J.R., Gamble, A.M., Whitelaw, Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression, J Exp Med, (1976), 144, 10-19
165. Vahlenkamp T. W. Tompkins M. B. Tompkins W. A. (2004). Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells. I Immunol 172, 4752–61.
166. Veldhoen M. Hocking R. J. Atkins C. J. Locksley R. M. Stockinger B. (2006). TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–89.
167. Vidovic D. Roglic M. McKune K. Guerder S. MacKay C. Dembic Z. (1989). Qa-1 restricted recognition of foreign antigen by a γδ T cell hybridoma. Nature 340, 646–50.
168. D.D.A., Vignali, L.W., Collison, C.J., Workman, How regulatory T cells work, Nature Rev Immunol, (2008), 8, 523-532
169. Von Boehmer H. (2005). Mechanisms of suppression by suppressor T cells. Nature Immunol 6(4), 338–44.
170. Wan Y. Y. Flavell R. A. (2007). “Yin-yang” functions of transforming growth factor-β and T regulatory cells in immune regulation. Immunol Rev 220, 199–213.
171. Weaver C. T. Harrington L. E. Mangan P. R. Gavriell M. Murphy K. M. (2006). TH 17 an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–88.
172. Weber C. A. Mehta P. J. Ardito M. Moise L. Martin B. De Groot A. S. (2009). T cell epitope: Friend or foe? Immunogenicity of biologics in context. Adv Drug Delivery Rev 61, 965–76.
173. Weiner H. L. (1997). Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunology Today 18(7), 335–43.
174. Weiner H. L. Friedman A. Miller A. Khoury S. J. al-Sabbagh A. Santos L. (1994). Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Ann Rev Immunol 12, 809–37.
175. M.M.P., Welters, S.J., Piersma, S.H., van der Burg, T regulatory cells in tumour-specific vaccination strategies, Expert Opin Biol Ther, (2008), 8, 9, 1365-1379
176. Wirnsberger G. Hinterberger M. Klein L. (2011). Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes. Immunol and Cell Biol 89, 45–53.
177. Wolf S. D. Dittel B. N. Hardardottir F. Janeway C. A. (1996). Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice. J Exp Med 184(6), 2271–8.
178. C.J., Workman, D.D.A., Vignali, Negative regulation of T cell homeostasis by LAG-3 (CD223), J Immunol, (2004), 174, 688-695
179. Xhao J. X. Zeng Y. Y. Liu Y. (2007). Fetal alloantigen is responsible for the expansion of the CD4+CD25+ regulatory T cell pool during pregnancy. J Reprod Immunol 75, 71–81.
180. Yanaba K. Bouaziz J.-D. Haas K. M. Poe J. C. Fujimoto M. Tedder T. F. (2008). A regulatory B cell subset with a unique CD1d hi CD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28(5), 639.
181. Yang H. Qiu L. Chen G. Ye Z. Lu C. Lin Q. (2008). Proportional change of CD4+ CD25 + regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril 89, 656–61.
182. Yang K. Li D. Luo M. Hu Y. (2006). Generation of HSP60-specific regulatory T cells and effect on atherosclerosis. Cell Immunol 243, 90–5.
183. Yong Z. Chang L. Mei Y. X. Yi L. (2007). Role and mechanisms of CD4 + CD25 + regulatory T cells in the induction and maintenance of transplantation tolerance. Transplant Immunol 17, 120–9.
184. Zeng D. Lewis D. Dejbakhsh-Jones S. (1999). Bone marrow NK1.1− and NK1.1+ T cells reciprocally regulate acute graft versus host disease. J Exp Med 189, 1073–81.
185. Zhang G. Y. Hu M. Wang Y. M. Alexander S. I. (2009). FOXP3 as a marker of tolerance induction versus rejection. Curr Opin Organ Transplant 14, 40–5.
186. Zhang Z. X. Ma Y. Wang H. (2006). Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway. J Immunol 177, 6920–9.
187. Zhao J. X. Zeng Y. Y. Liu Y. (2007). Fetal alloantigen is responsible for the expansion of the CD4+CD25+ regulatory T cell pool during pregnancy. J Reprod Immunol 75, 71–81.
188. Zhou L. Lopes J. E. Chong M. M. Ivanov I. I. Min R. (2008). Tgf-β-induced FOXP3 inhibits TH 17 cell differentiation by antagonizing Rorγt function. Nature 453, 236–40.